Results 1 to 10 of about 10,003 (163)
Myocardial no-reflow in humans.
Journal of the American College of Cardiology, 2009 In a variable proportion of patients presenting with ST-segment elevation myocardial infarction, ranging from 5% to 50%, primary percutaneous coronary intervention achieves epicardial coronary artery reperfusion but not myocardial reperfusion, a condition known as no-reflow. Of note, no-reflow is associated with a worse prognosis at follow-up.
Giampaolo Niccoli, Francesco Burzotta
exaly +5 more sources
ARYA Atherosclerosis, 2010 Definition No reflow is a phenomenon in which myocardial ischemia and reduced antegrade flow occur despite the absence of proximal stenosis, spasm, dissection, or embolic cut off of major distal branches.1 In another word no reflow phenomenon means ...
Omid Hashemifard
doaj +1 more source
International Journal of Cardiology: Heart & Vasculature, 2022 Background: The release of lipid-laden plaque material subsequent to ST-segment elevation myocardial infarction (STEMI) may contribute to the no-reflow phenomenon.
Yosuke Katayama +8 more
doaj +1 more source
Platelet-To-Lymphocyte Ratio as a Predictor of No-Reflow after Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis [PDF]
Journal of Cardio-Thoracic Medicine, 2019 Introduction: No-reflow increases the complications and mortality rate of primary percutaneous coronary intervention (PCI). Therefore, it is important to identify patients at a higher risk of developing no-reflow.
Amin Saberi +3 more
doaj +1 more source
Bagcilar Medical Bulletin, 2023 Objective: No-reflow phenomenon is one of well-known complications of percutaneous coronary intervention (PCI). The rate of no-reflow phenomenon was reported between 2-44% differing on the accompanying situations and more frequent in acute myocardial ...
Esra Dönmez +3 more
doaj +1 more source
Journal of Diabetes Research, 2021 Although percutaneous coronary intervention (PCI) significantly improves the prognosis for myocardial infarction, the no-reflow phenomenon is still the major adverse complication of PCI leading to increased mortality, especially for the patients with ST ...
Fang Liu +5 more
doaj +1 more source
, 2021 This report introduces the REFLOW Framework as a supportive model to enable agency and participation of municipalities, SMEs, and citizens’ associations in the development of CE practices and governance. After introducing the key terminology informing the REFLOW's understanding of cities' transition towards CE, this deliverable provides the most ...
Parisi, Cristiana +2 more
openaire +4 more sources
Circulation, 2002 Because total coronary artery occlusion was found in the early hours of transmural myocardial infarction, most of our research interest and treatment strategies focus on epicardial coronary arteries.1 Little attention, however, is paid to the coronary microvasculature.
Shereif H, Rezkalla, Robert A, Kloner
openaire +2 more sources
No-reflow phenomenon after primary percutaneous coronary intervention: To reflow or not to reflow?
Research in Cardiovascular Medicine, 2017 Turgay Celik +3 more
doaj +2 more sources
BMC Cardiovascular Disorders, 2020 Background No-reflow occurs in 3–4% of all percutaneous coronary interventions (PCIs) and has a strong negative impact on clinical outcomes of acute coronary syndrome (ACS). Therefore, the discovery of a biomarker that can early predict the occurrence of
Nian-Peng Song +5 more
doaj +1 more source